Chromium histidinate reduces brain damage caused by insulin-induced hypoglycemia

Basit Öğe Kaydı
dc.contributor.authorKomorowski, James Richard
dc.contributor.authorTuzcu, Mehmet
dc.contributor.authorŞahin, Nurhan
dc.contributor.authorHayirli, Armagan
dc.contributor.authorŞahin, Kazım
dc.date.accessioned2026-08-12T18:13:03Z
dc.date.issued2011
dc.departmentFırat Üniversitesi
dc.descriptionExperimental Biology Meeting 2011 -- APR 09-13, 2011 -- Washington, DC
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipAmer Assoc Anatomists (AAA),Amer Physiolog Soc (APS),Amer Soc Biochem & Mol Biol (ASBMB),Amer Soc Investigat Pathol (ASIP),Amer Soc Nutrit (ASN),Amer Soc Pharmacol & Expt Therapeut (ASPET)
dc.identifier.issn0892-6638
dc.identifier.urihttps://hdl.handle.net/11508/64182
dc.identifier.volume25
dc.identifier.wosWOS:000310708404873
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherFederation Amer Soc Exp Biol
dc.relation.ispartofFaseb Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleChromium histidinate reduces brain damage caused by insulin-induced hypoglycemia
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu